Cat. #162305
Meningioma grade III NCH93 cell line
Cat. #: 162305
Organism: Human
Tissue: Brain
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Christel Herold-Mende
Institute: Heidelberg University
Primary Citation: Jungwirth et al. 2021. Cancer Lett. 506:1-10. PMID: 33652084.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Meningioma grade III NCH93 cell line
- Cancer type: Brain cancer
- Organism: Human
- Tissue: Brain
- Growth properties: Mixed - adherent and suspension
- Description: Meningioma grade III cell line, NCH93
- Biosafety level: 2
Handling
- Growth medium: Dulbecco’s Modified Eagle Medium supplemented with 10% fetal bovine serum, 2% glutamine and 1% penicillin/streptomycin
- Temperature: 37°C
- Atmosphere: 5% CO2
References
- Yu et al. 2021. Cancers. 13(23):5898. PMID: 34885009.
- Jungwirth et al. 2021. Cancers. 28:506:1-10, PMID: 33652084.
- Jungwirth et al. 2019. Cancers. 11(4):545. PMID: 30991738.
- Jungwirth et al. 2021. Cancer Lett. 506:1-10. PMID: 33652084.



![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)



